A case-control study evaluating the efficacy and safety of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis.
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2015
At a glance
- Drugs Acetylcysteine (Primary) ; Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 31 Dec 2014 New trial record